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card*ac anomatios ~,~ cunently unknown, isolated LVNC has been shown to 
occur with X.linked inhentanco and mutations in the taffazin (G45) gone and 
protein The purpose of th~s teporl is to desenba the ¢1in¢~1 findings of LVNC 
with VSD in two children which suggest a possible etiology different from that 
of iSO!a|(~ LVNC 
M~tf~:  TwO neonates who prosentnd with heart taduro were identified 
by echoc~lrdiography as hawng LVNC with associated VSD Subsequent 
clintc,~l work-up employed the Pediamc Cardiomyop~thy RegistW diagnos- 
tm a~nlhm which included evaluation o! serum el~rolytes, eamltine and 
aolt-eamitiea profiles, aotl.CeA dehydfogenases, serum am,no acids, unne 
organic acids, and skeletal muscle I~opsy, with of without endomyocardtat 
b~psy, for hislology, e!O~-'tron mzcfos¢opy (EM), msl~mtory chain enzyme 
analysis, and mitochondtial DNA (mtDNA) mutation screen 
Re.~ulP3. In both patlenls (2 female~) skelefa! muscle biopSy demonstr~t ~) 
abnolma! mltt~bendnal nund~er a!~! ~ppeam~ by histology and EM (one 
patient) bad intran.tochondnal inctusions), consistent with e mitochonclnal 
proliferative d~sea~lo+ Enzyme stainin~ Showed a r~J~++ticn of cytochrom~ 
omdase. No mutabons in G45 were Identified. Analysis for mtDNA mut-llons 
IS currently tmderway 
Conctusmn: LVNC wffh V$13 is assooeted with abnormal m~tochondna 
and m, tochondna! resp~ralely chain abnormatibes. Tbemfore, LVNC appears 
to be frenetically hEterocjeneous. Sl:~Clhc mtDNA mutations respenmble for 
the chscrder am 13elqg sought 
I 1014-160] Outcome of Infantile Familial Dilated 
Cardlomyopathy. Comparison With the 
Non-fami l ia l  D isease  in Pediatr ic Age Group 
M A. Set/am. K.B. Manasra, M. Pahleo. ARAMCO Dhahran Hea#h Center. 
Dhahran, Sauo~ Arabia 
O ~ :  TO desc~nbe the natural h~ston/of famdial Idiopathic D=alated Car- 
ckomyopathy (IDCM) presenting in intatqcy and to compare its clinical course 
w~th the non-famdlal form of IDCM 
Bac~gn~und: Familial eh~togy of IDCM has been reported repeatedly 
among (bfferent age groups. The outcome of this dmhnct form of IDCM when 
presents exclusively in inta~:y has not b~on descnbed. 
Methods; Four famdms with a total of 17 cases of IDCM who presented 
before two years ol age are the focus of this study. Each fam, ly has at least 3 
affected sibhngs. No~e of the~e petmnts (Pts.) has any co~:jenrtal or acquired 
head dF~ease. The ctin¢cal CouP3e of these mfant~ was compared wr~ that of 
38 ~ v e  children wdh IDCM 
Echo~rdiogrephy was the main modal~,, for chagnosis and follow-up 
None of these Pts. underwent heart transplantation Medical therapy was the 
only treatment offered. 
Re~ul~s All cases of fami!ial InCM presented before 2 years of age Four- 
leon ut mere u~eo a;.;c ~r-tore 2 yea~ of age ttctal modality 88<'=) There 
was no difference boh'.'een these famd~al cases and non-farad=at ones =n sex 
dcstnbubon, age at diagnoszs, location o! referral, preceding viral mfect~on. 
echocard=ograph~c LV shortening fraction on presentation, conventional drug 
therapy, usage of steroids. }.-globulins or B-Blockers. Acute IV inotropics and 
long term vasoddators were used much more in familial cases (P = 003 ano 
0.006 respectively). The rnalor difference between the two groups, however. 
was sun/ival; 2~17 (12%) among familial cases versus 28/38 (74%) of non- 
familial cases. P - 0.0001. Among non-familial cases. LV systolic function 
returned to normal in 37% ot the cases ~,~thin 6 months of presentahon and 
remained abnormal in 37% of them up to the latest follow up. 
Conc/usrons: Familial IDCM (30% of IDCM cases in our pediatnc popu- 
lation) carnes a very poor prognosis when presents in infancy. Heart trans. 
plantation (H. Tx,) should be considered as soon as possible once diag- 
nosis is made. The non-tamilial disease has 74% probability of survival 
Therefore aggressive medical therapy should be attempted before H. Tx. is 
sought. 
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~ Ventricular in Patients With Dilated Funct ion  
Card iomyopathy  is Improved by VDD Pacing at  
Left but  Not  R ight  Ventr icu lar  Sites 
D.A. Kass, C.-H. Chert, B. Fetics, M. Talbot. E. Nevo. M. Nakayama. Johns 
Hopkins Unwersi~ Baltimore MD. USA 
Background: Ventncular pre-excitahon by VDD pacing with a shod AV delay 
is a potential therapy for patients with dilated heart failure (DCM). However. 
th0 optrmat paczng szto may not I~ 1~o nghl ventnculat apex ~s ,s mostly 
w~G~ely employ(~l 
MethOcl~: Cardiac c~thatonzatlon by pressure-volume an~lys~s wa~ per, 
formed in 14 pts with DCM (NYHA.II!-!V. me~lrt EF 19 .~ 2%i Base!ins QR$ 
and PR .ntervals were t47 ~ g 2 ms and 207 ~ 21 ms, respeettvety VDD 
I:~lcm9 was perfon/~d with activation at the RV apex (RVA), rf~d RV septum 
(RVS), LV base (LV~, vi~ coroea~ veno~s p~ctng wire), of b~,~ntn¢~r (RVA 
* LV) Steady.state d~t~ measured pnof to and t ~2 mm a~et the onset of 
pacing were recorded 
Results: Only VD_O p~c,n~ I at the LVB induce(~ slgn!f~..ant changes m LV 
syslotic function, if~|e~ti!~l by a n,~e In peak pressure (Psys) ar~ m~L~k,~al 
pressure (~nvative (d~/dt~,) 
FIVA RV~ LVB RVA * LV 
Psys 27 ~ 20 (~7 ~ 09 73 t 1 t 'tr 23 ,- I 7 
Datalr~tai~heare%~% i e, emfromsmusm~thmNSR.',p, O001veNSR t p, 00t 
vsRVA ! -p 001 vsR~S 
Results with biventncutaf pacing were worse than wrlh single-site LV 
pacing PV loops obtruded in a subset of patients were consistent with these 
(~la. The contractile response to pacing s~gncfmantly correlated w~th baseline 
ORS duration (p = 0.00~), mdcatmg the importance of electro-mechanical 
a~:tivatio. ¢~,;.~y lu tim re,~po~,se 
Conctusmns. VDD pacing can substantmlly =mprove LV systolic functlon 
~n DCM patients, but this effect depends upon the site of actwatlon, LV pacing 
m preferable over RV or bwenmcular pacing 
• Cl in ica l  and Object ive improvements  in Severe 
Congest ive  Heart Fai lure Pat ients Using 
Univentricular or Blventricular Pacing: 
Preliminary Results of a Randomized Prospective 
Study 
A. Auncch~o. C. 3tel:bnnk. M Block, P Modensen. On Dehalf of the 
PATH-CHF fnvest~gators: Unevetsdy Hospital Magc/eburg. Germany 
I ~ n ;  Prewous non-randomized studms evaluating pacing therapy in 
severe congestive heart failure (CHF) have reported conflicting results. The 
"PATH-CHF" (PAcing THerapy in CHF) study is a prospestwe mu~center 
study companng umventncular (Urn), i.e. right (RV) or lefl ventncular (LV) 
s~mulabon, to bnrentncular (BN) paong in patients (pts) with severe CHF 
Matt.:/s: After implant of 2 pacemakers, each pt was randomized m a 
cross-over study, including 4 weeks of Um pacing and 4 weeks o! RN pacing 
separated by a wash-out penod Optimal Um pacmg mode and AV delays 
were selected by extensive mtraoperatwe test 
Results. The study included 16 pts with @lated congestwe cardtomyopathy 
of any ongl=, stable NYHA Ill/IV. PR mten~al • 150 ms and ORS duration 
• 120 ms. Mean age was 59 ~ 5 yrs. Mean LV elation fraction was 22 ± 7% 
Changes in NYHA class, quality-of-life tOOL), 6-minute walking test (6-mm), 
maximal work rate (WR) and VO2 at anaerobic threshold (AT VO~) are listed 
below 
Pre-lmplant Um BIV p varue 
NYHA 33:03  15~05 14=04 -0001 
QOL (Mlnnesc, ta score) 54 .- 16 25 = 22 12 = 15 ~ 0001 
6-m.,n (m) 295=61 375=106 410 ~ 64 -001 
WR tWans) 62 ++ 21 92 : 42 90 ~ 40 - 0 05 
AT VO2 t mL kg.,rnm) 90 :13  117t25 134~25 -005 
P values re|el5 to comparison between !)m +3rid BIV ,..s Pre-fn~t~tt~ 
Conclusions: These data demonstrate significant short-term objectrve ,m- 
provement dunng Um or B~V pacing in selected CHF pts. Long.term foflow-up 
will allow confirmation of these early findings. 
i1015-31 i Excellent Effect on Left Ventrlcular Despite an J Performance, Carvedilel Falls to Improve the 
Pulmonary Function and Peak Exercise 02 
Uptake  in Chronic Heart Failure. Any  Link? 
M GuazzL P.G. Agostoni. N. TtLm,qsi. M.D. Guazzi. Institute of Cardtolog~ 
University of Mdan. CN R . Mdan. Italy 
Background: Disturbances in ventilation and in pulmonary gas transfer (stress 
failure of alveolar-capillary membrane) due to chronic head fadure (CHF). 
participate in limiting peak exercise oxygen uptake (pVO2). This study was 
aimed at investigating the effects of carvedilol on lung function in CHF. as ~t 
improves left ventdcular dysfunction and not pVO2 
Methods: 21 NYHA class I1-111 pabents given digoxin and furosem~de. 
were randomized (two t'~ one) to ca~,~ilol (25 mg I0 d !4 pts) or placebo (7 
